Figure Legends

S4. Knockdown of JMJD2B using siRNA and its effect on TGF-β1 and IL-1β driven
EndMT. (A-E) HUVECs were treated either with siRNAs targeting JMJD2B or control (siScr) siRNA, followed by EndMT induction by TGF-β1 and IL-1β. mRNAs were determined by RT-qPCR, normalized to RPLP0. Data are represented as fold to siScr Ctrl (n=5). mRNA levels of (A) ZEB2, (B) CD44, (C) NOS3 and (D) CD34. IF-staining of (E) PDGFRβ in red, CDH5 in green and nuclei in blue (scale bar = 10µm). Data are depicted as mean ±SEM. Statistical significance was determined using Student's t-test; *P<0.05. S9. Effect of AKT3 on EndMT. mRNA expression level of (A) SM22 and (B) CNN1 after siRNA-mediated knockdown of AKT3 followed by EndMT induction (n=4). Data are depicted as mean ±SEM. Statistical significance was determined to Ctrl respectively using Student's t-test; *P<0.05.
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Endothelial-to-mesenchymal transition assay
For the EndMT assay two distinct media were used referred to as either full medium ("Ctrl") or differentiation media ("DM"). The composition of the media is listed in the table below. For the assay, 4 x 10 5 HUVEC were seeded in a 60 mm cell culture dish. After 24°h, cells were incubated in Ctrl media or DM with either 10 ng/ml TGF-β2 (referred as "EndMT", #302-B2, R&D System) or 10 ng/ml TGF-β1 (#240-B, R&D System) and/or 10 ng/ml IL-1β (#200-01B, Peprotech). After additional 48 h of incubation, the treatment was repeated. After a total of 96 h, RNA was isolated.
Cell culture and differentiation media: Lentivirus stocks were produced in HEK293T cells using pCMVΔR8.91 as packaging plasmid and pMD2.G (Addgene #12259). Empty backbone-vectors were used as control. HUVECs were transduced, followed by EndMT induction as described before.
RNA and Protein were isolated after 96 h and analyzed by qRT-PCR or Westernblot.
Small interfering RNA knockdown
For siRNA-mediated gene silencing, 4 x 10 5 HUVEC were seeded in a 60 mm cell culture dish. After 24 h, cells were transfected with GeneTrans II (#0203B Mobitec) as described previously using siRNA pools or single sequences listed in the table below. 2 EndMT and hypoxia treatment were started 24 h after transfection as described above.
SiRNA pools and sequences: 
In vitro analysis of CDH5 protein level
After EndMT treatment of seven days, the intensity of the CDH5 staining was measured with ImageJ (staining procedure is described in the immunofluorescence section). For each condition, five random fields were analyzed per replicate.
In vitro analysis of SM22 positive cells
After EndMT induction, SM22 positive cells were counted based on the SM22 staining (staining procedure is described in the immunofluorescence section). We distinguished between cells, which were negative for SM22, positive or showed an intermediate protein level. For each condition, 9-10 random fields were analyzed per replicate.
RNA-Sequencing
RNA was isolated as described before. 900ng of total RNA was used as input for whole 
Microarray analysis
RNA was isolated as described in the RNA isolation section. Gene-expression analysis was performed using the GeneChip Human Exon 1.0 ST array (#900651 Affymetrix)
following the supplier's instructions. Data were analyzed by using the Exon Array Analyzer (EAA) Web interface (http://eaa.mpi-bn.mpg.de/). 9 Data were in depth bioinformatically analyzed using GO-panther, KEGG-pathway and GAD-disease analysis-tool.
Chromatin immunoprecipitation sequencing (ChIP-Seq)
The ChIP Sequencing protocol was adapted from C. Schmidl et al. with the following changes. 10 HUVECs grown in T175 culture flask were washed with 10 ml PBS, 
Animals
All animal experiments were performed in accordance with the animal welfare guidelines and German national laws and were authorized by the competent authority (Regierungspräsidium Darmstadt, Hessen, Germany). C57BL/6J Jmjd2b fl/fl mice were obtained from Hitoshi Okada and already described. 12 Mice were crossed with C57BL/6J
Cdh5-CreERT2 mice (obtained from the Jackson Laboratory) and treated with 2 mg/injection tamoxifen for 2 weeks (n=7-10; female and male, 10 weeks-old). After additional 2 weeks, left anterior descending (LAD) coronary artery ligation surgery induced myocardial infarction was performed.
Myocardial infarction (MI)
MI was performed in 12 to 14 week old male and female Cdh5-iCre; Jmjd2b fl/fl mice.
The animals were anesthetized with isoflurane and analgesia was delivered by an 
Isolation of liver endothelial cells (ECs):
To check the knockout efficacy of Jmjd2b we isolated ECs from the liver. Mice were first perfused with GBSS (#G9779, Sigma), the lung was removed and dissociated with collagen type II (#17101-015 Gibco; 600 U/mice) using the Gentlemacs. After 30 min at 37°C, cells were filtered with a 200 µm pore cell strainer and centrifuged at 290 x g, 10 min. The cell pellet was mixed with nycodenzsolution (35 %; #1002424 AXIS-SHILD) and overlayed with GBSS. After centrifugation without brake, cells were washed twice with cold MACS-Puffer (1 % FCS, 2 mM EDTA in PBS) and incubated with LSEC-Beads (#130092007 Miltenyi) for 30 min. Endothelial cells were than separated using a magnet based elution. RNA was isolated and expression was analysed using qRT-PCR with primers described before.
Immunohistochemistry (IHC)
Mouse hearts 14 days post AMI were perfused with HBSS with Ca 2+ and Mg 2+ and fixed with 4% PFA. The hearts were embedded in paraffin and sectioned at 4 µm thickness using a microtome. Sections were incubated at 60 °C for 30 min, de-paraffinised and rehydrated. To analyse fibrosis, sections were incubated in 0.1 % Picro Siriusred F3BA solution for 1 h (Siriusred #1A280 Waldeck GmbH, Picric adic #6744.1GA Sigma Aldrich), washed with acidified water, dehydrated and cleared with xylene. Siriusred staining intensity was measured using ImageJ, normalized to the total tissue.
For antibody stainings, sections were incubated in citratbuffer (pH 6, 0.1 M) and blocked with 5 % donkeyserum. Tissues were stained with S100A4 (1:100, #07-2274 Milipore), biotinylated Isolectin B4 (1:50, #B1205, Vector) and Hoechst 33342 (1:400, #AS83218 
